Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Thomas Peter Gschwend has worked on the following 7 EPO patent applications which have been published in the last five years:

EP13734849

NEW PROCESS FOR THE PREPARATION OF 2-CYCLOPENTYL-6-METHOXY-ISONICOTINIC ACID

IPC classification:
C07C 45/67, C07D 213/79, C07D 213/85
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13779378

PROCESS FOR THE PREPARATION OF!(2Z,5Z)-5-(3-CHLORO-4-((R)-2,3-DIHYDROXYPROPOXY)BENZYLIDENE)-2-(PROPYLIMINO)-3-!(O-TOLYL)THIAZOLIDIN-4-ONE AND INTERMEDIATE USED IN SAID PROCESS

IPC classification:
C07C 47/575, C07D 277/54
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION IN PROGRESS
EP11715042

3-(HETEROARYL-AMINO)-1,2,3,4-TETRAHYDRO-9H-CARBAZOLE DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS

IPC classification:
A61K 31/403, A61P 11/06, C07D 209/88
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14715427

PYRIDIN-4-YL DERIVATIVES

IPC classification:
A61K 31/4433, A61P 37/00, C07D 413/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION REQUESTED
EP14715428

NOVEL ACRYLAMIDE DERIVATIVES AS ANTIMALARIAL AGENTS

IPC classification:
A61K 31/435, A61K 31/445, C07D 211/58, C07D 213/75, C07D 401/12, C07D 401/14, C07D 403/12, C07D 413/14, C07D 417/14, C07D 471/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION REQUESTED
EP12704125

2-METHOXY-PYRIDIN-4-YL DERIVATIVES

IPC classification:
A61K 31/4439, A61P 37/00, C07D 413/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11773875

NEUROPEPTIDE Q AS MODULATOR OF GPCR GALR2 AND USES THEREOF

IPC classification:
G01N 33/566
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Thomas Peter Gschwend, Actelion Pharmaceuticals Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature